Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner.

Fife firm Eos Advisory leads £1.7m investment into cancer treatment company Cumulus Oncology

Clare Wareing and Alan Wise of Cumulus Oncology with Mark Beaumont and Andrew McNeill of Eos Advisory.
Clare Wareing and Alan Wise of Cumulus Oncology with Mark Beaumont and Andrew McNeill of Eos Advisory.

St Andrews-based investment firm Eos Advisory has led an investment round into Europe’s first oncology drug discovery accelerator.

The £1.7 million funding round into Edinburgh-based Cumulus Oncology represents one of the Fife firm’s largest deals to date.

Founded in 2017, Cumulus manages spin-out companies created specifically to develop novel anti-cancer treatments.

The new funding will enable Cumulus, which is led by Clare Wareing, to continue to scale and take advantage of “significant opportunities in Europe”.

Eos Advisory invests and co-invests in innovative science, engineering and technology companies and supports them from seed round to series A stage.

Andrew McNeill, managing partner at Eos Advisory, said: “With a track record in scaling and exiting biopharmaceutical ventures, Clare is a founder who combines significant market understanding with a clear vision of what she wants Cumulus and its portfolio companies to achieve.

“Clare has assembled a world-class team and we are enthused by their keen focus, deep sector expertise and drive to consolidate Cumulus’s position as Europe’s first and most successful oncology drug discovery accelerator.”

The investment was supported by the Scottish Investment Bank, the investment arm of Scottish Enterprise, Alba Equity, Apollo and Investing Women.

Cumulus founder and chief executive Ms Wareing said: “While the business model is well developed in the US, Cumulus is leading the way in Europe.

“Having spent three years carefully curating a high-calibre team and building a portfolio of oncology asset-centric spin-out companies, we are poised to scale the business.

“Venture capital and trade investors see the value of the European biotech sector, which has matured markedly over the last few years evidenced by a three-fold increase in venture financing, the doubling of European VC funds and increased investment from the US.”

Eos Advisory counts record-breaking cyclist Mark Beaumont as part of its team of partners and fund managers.

rmclaren@thecourier.co.uk

Already a subscriber? Sign in

[[title]]

[[text]]